Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer surv...

por Cabezón, M., Malinverni, R., Bargay, J., Xicoy, B., Marcé, S., Garrido, A., Tormo, M., Arenillas, L., Coll, R., Borras, J., Jiménez, M. J., Hoyos, M., Valcárcel, D., Escoda, L., Vall-Llovera, F., Garcia, A., Font, L. L., Rámila, E., Buschbeck, M., Zamora, L.
Publicado 2021

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

por Díaz-Beyá, M, Brunet, S, Nomdedéu, J, Cordeiro, A, Tormo, M, Escoda, L, Ribera, J M, Arnan, M, Heras, I, Gallardo, D, Bargay, J, Queipo de Llano, M P, Salamero, O, Martí, J M, Sampol, A, Pedro, C, Hoyos, M, Pratcorona, M, Castellano, J J, Nomdedeu, M, Risueño, R M, Sierra, J, Monzó, M, Navarro, A, Esteve, J
Publicado 2015

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

por Martinez-Lopez, J, Sanchez-Vega, B, Barrio, S, Cuenca, I, Ruiz-Heredia, Y, Alonso, R, Rapado, I, Marin, C, Cedena, M-T, Paiva, B, Puig, N, Mateos, M-V, Ayala, R, Hernández, M-T, Jimenez, C, Rosiñol, L, Martínez, R, Teruel, A-I, Gutiérrez, N, Martin-Ramos, M-L, Oriol, A, Bargay, J, Bladé, J, San-Miguel, J, Garcia-Sanz, R, Lahuerta, J-J
Publicado 2017